Pediatric Dermatology

Latest News

Review Finds Topical Erythromycin, Azithromycin, and Metronidazole Most Common Treatments for Pediatric Rosacea
Review Finds Topical Erythromycin, Azithromycin, and Metronidazole Most Common Treatments for Pediatric Rosacea

November 2nd 2023

Additionally, investigators found that several patients in the review had rosacea induced or exacerbated by the use of topical corticosteroids on the face.

Lisa Swanson, MD, PhD: Clinical Pearls in Pediatric Dermatology
Lisa Swanson, MD, PhD: Clinical Pearls in Pediatric Dermatology

October 28th 2023

Camp Wonder: Supporting Children With Life-Threatening Skin Diseases
Camp Wonder: Supporting Children With Life-Threatening Skin Diseases

October 21st 2023

62.2% of Parents Report Severe, Very Severe Stress at Time of Child With Congenital Melanocytic Nevi's Birth
62.2% of Parents Report Severe, Very Severe Stress at Time of Child With Congenital Melanocytic Nevi's Birth

October 18th 2023

Given Prevalence, Study Underscores Need for Education Surrounding Pediatric Dermatoses in Patients With Skin of Color
Given Prevalence, Study Underscores Need for Education Surrounding Pediatric Dermatoses in Patients With Skin of Color

October 16th 2023

Latest CME Events & Activities

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Cases and Conversations™: Enhancing Diagnosis and Evaluation of Generalized Pustular Psoriasis in Advanced Practice Settings

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Facing the Changing Landscape for Neuromodulators and Dermal Fillers

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?

View More

"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation

View More

PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa

View More

Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)

View More

© 2023 MJH Life Sciences

All rights reserved.